News FDA and EMA to work more closely on paediatric drug regulati... FDA and EMA hope to streamline development of paediatric plans.
News EU data rules to impact pharma interaction with doctors Data protection regs will require better data management.
News Pfizer looks to confirm US licence for breast cancer pill Pfizer has filed late stage data with FDA.
News EU approval for Crohn's another boost for fast-growing Stela... J&J unit's blockbuster gets new use.
News PTC's muscular dystrophy drug can stay on EU market - regula... But PTC must conduct further trial to confirm Translarna's benefits.
News Biogen/Ionis could launch rare disease drug within weeks Companies prepare for launch of Spinraza after phase 3 success.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
